Last updated: 2026-09-07 17:08:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
GLOBUS MEDICAL INC. (GMED) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $78.28, with a market capitalisation of $10.51B and a P/E ratio of 19.63. Over the past 52 weeks, its price has ranged from $54.15 to $101.40. This page covers its latest market performance, valuation, price trends and company information.
$10.51B | |
$77.23 | |
$101.40 | |
$10.26 | |
$78.12 | |
937.83K | |
1.59M | |
19.63 | |
$101.40 | |
$54.15 | |
-- | |
-- |
GLOBUS MEDICAL INC. (GMED) last closed at $78.12 as of 2026-09-05 00:01:00, unchanged from the previous close of $78.12.
During the latest regular trading session, GMED traded between $10.26 and $101.40, with a volume of 937.83K shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, GLOBUS MEDICAL INC. (GMED) moved from $82.54 to $78.28, representing a decline of 5.17% ($4.26).
The stock traded between $77.07 and $84.01 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.05 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 51.1%
GMED is currently trading at $78.28, placing it 51.1% of the way from its 52-week low of $54.15 to its 52-week high of $101.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 6000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of GLOBUS MEDICAL INC. (GMED) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.